These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20370728)

  • 1. Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis.
    Bamba S; Tsujikawa T; Inatomi O; Nakahara T; Koizumi Y; Saitoh Y; Sasaki M; Fujiyama Y; Andoh A
    J Gastroenterol Hepatol; 2010 Mar; 25(3):494-8. PubMed ID: 20370728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous cyclosporin in ulcerative colitis: a five-year experience.
    Cohen RD; Stein R; Hanauer SB
    Am J Gastroenterol; 1999 Jun; 94(6):1587-92. PubMed ID: 10364029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis.
    Moskovitz DN; Van Assche G; Maenhout B; Arts J; Ferrante M; Vermeire S; Rutgeerts P
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):760-5. PubMed ID: 16716758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cyclosporin with corticotropin for refractory ulcerative colitis.
    Okamura S; Aoki H; Ohashi S; Urano F; Shimodaira M; Kanamori S; Ishikawa H; Segawa K
    Hepatogastroenterology; 2003; 50(49):91-4. PubMed ID: 12629999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 17-year single-center experience with the use of azathioprine to maintain remission in ulcerative colitis.
    Actis GC; Fadda M; Pellicano R; David E; Rizzetto M; Sapino A
    Biomed Pharmacother; 2009 Jun; 63(5):362-5. PubMed ID: 18657949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
    Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis.
    Fernández-Bañares F; Bertrán X; Esteve-Comas M; Cabré E; Menacho M; Humbert P; Planas R; Gassull MA
    Am J Gastroenterol; 1996 Dec; 91(12):2498-9. PubMed ID: 8946973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early onset steroid-dependent ulcerative colitis is a predictor of azathioprine response: a longitudinal 12-month follow-up study.
    Chebli LA; Felga GG; Chaves LD; Pimentel FF; Guerra DM; Gaburri PD; Zanini A; Chebli JM
    Med Sci Monit; 2010 Feb; 16(2):PI1-6. PubMed ID: 20110928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of a conservative approach in severe ulcerative colitis.
    Daperno M; Sostegni R; Scaglione N; Ercole E; Rigazio C; Rocca R; Pera A
    Dig Liver Dis; 2004 Jan; 36(1):21-8. PubMed ID: 14971812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of response to cyclosporine in steroid-refractory ulcerative colitis.
    Cacheux W; Seksik P; Lemann M; Marteau P; Nion-Larmurier I; Afchain P; Daniel F; Beaugerie L; Cosnes J
    Am J Gastroenterol; 2008 Mar; 103(3):637-42. PubMed ID: 18047542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin for severe ulcerative colitis attacks.
    Danalioglu A; Kaymakoglu S; Mungan Z; Karaca C; Demir K; Durakoglu Z; Besisik F; Boztas G; Cakaloglu Y; Okyen A
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxcviii-ccc. PubMed ID: 15244207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial.
    Musch E; Andus T; Malek M; Chrissafidou A; Schulz M
    Z Gastroenterol; 2007 Dec; 45(12):1235-40. PubMed ID: 18080224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study.
    Actis GC; Fadda M; David E; Sapino A
    BMC Gastroenterol; 2007 Mar; 7():13. PubMed ID: 17389040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
    Yamamoto S; Nakase H; Matsuura M; Masuda S; Inui K; Chiba T
    J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.